Skip to content

Taxes Paid at other companies

Revvity logo
RevvityRVTY
$38.73M-56.9%
Agilent Technologies logo
Agilent TechnologiesA
$215M-6.1%
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC
$92M+1.1%
Bruker logo
BrukerBRKR
$24.3M-63.4%
Danaher logo
DanaherDHR
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$7.56B+10.3%
Enterprise value$8.04B+4.2%
P/E44.8×
P/S2.9×+0.2×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories's taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bio-Rad Laboratories's taxes paid?
Bio-Rad Laboratories (BIO) reported taxes paid of $11M in Q1 2026.
How has Bio-Rad Laboratories's taxes paid changed year-over-year?
Bio-Rad Laboratories's taxes paid increased by 39.2% year-over-year, from $7.9M to $11M.
What is the long-term trend for Bio-Rad Laboratories's taxes paid?
Over 4 years (2021 to 2025), Bio-Rad Laboratories's taxes paid has grown at a -17.2% compound annual growth rate (CAGR), from $134.68M to $63.4M.
What does taxes paid mean?
Represents the actual cash outflows for income taxes to various tax jurisdictions. This metric reflects the company's effective cash tax rate and the timing of tax payments relative to accounting income.